India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Join Pharma | Login

	Editorial


	STILL A TOOTHLESS TIGER
	Tuesday, July 1, 2025
	Unethical marketing practices by the pharmaceutical companies have been a major issue the country has been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Tango Therapeutics begins patient dosing in phase 1/2 trial of TNG462 plus Revolution Medicines’ daraxonrasib or zoldonrasib to treat RAS-mutant MTAP-deleted pancreatic or lung cancer
17:30 [IST]	Aldeyra Therapeutics gets US FDA’s special protocol assessment agreement letter for its drug candidate, ADX-2191 to treat primary vitreoretinal lymphoma
17:00 [IST]	Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product
16:00 [IST]	Bone Biologics seeks US patent for bone regeneration technology
15:00 [IST]	Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection
14:00 [IST]	BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US

more news >>

TOP NEWS


08:00 [IST]	DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity
08:00 [IST]	Indian pharma firms invited to supply medicines to Venezuela's Ministry of Education
08:00 [IST]	Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia
08:00 [IST]	A N Mohan re-elected president, Antony Tharyan, general secretary as AKCDA tackles expiry settlement debate
08:00 [IST]	India’s medical expertise in robotic surgeries draws patients from across the world
08:00 [IST]	DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Ambry Genetics’ CARE programme validated for accuracy in identifying patients for hereditary cancer testing
17:00 [IST]	Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research
16:00 [IST]	Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom
15:00 [IST]	Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
14:00 [IST]	KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada
13:00 [IST]	US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

AI minimises risks associated with med documentation Technology disrupts Indian lab equipment landscape Healthcare landscape undergoing dramatic shift PharmaTech Expo to drive growth and competitiveness Formulations industry going from strength to strength

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers